Skip to main content

Grafa News and Videos — Page 1508

Latest

Grafa

Hoth Therapeutics preclinical data shows GDNF reprograms liver fat metabolism

Hoth Therapeutics (NASDAQ:HOTH) announced on Tuesday, April 14, 2026, positive preclinical results for its HT-VA program, showing that parenteral administration of Glial Cell-Derived Neurotrophic Factor (GDNF) can fundamentally alter liver fat metabolism.

Read more: Hoth Therapeutics preclinical data shows GDNF reprograms liver fat metabolism
Grafa
Technology

Horizon Aircraft advances Cavorite X7 development with new strategic partnerships

Horizon Aircraft (NASDAQ:HOVR) reported its third-quarter fiscal 2026 financial results on Tuesday, April 14, 2026, detailing a strengthened balance sheet and a series of manufacturing milestones intended to bring its flagship hybrid-electric aircraft to market by 2027.

Read more: Horizon Aircraft advances Cavorite X7 development with new strategic partnerships

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift